SARS-CoV-2 specific nanobodies neutralize different variants of concern and reduce virus load in the brain of h-ACE2 transgenic mice

Since the beginning of the COVID-19 pandemic, there has been a significant need to develop antivirals and vaccines to combat the disease. In this work, we developed llama-derived nanobodies (Nbs) directed against the receptor binding domain (RBD) and other domains of the Spike (S) protein of SARS-Co...

Descripción completa

Detalles Bibliográficos

Autores principales:	Pavan, Florencia, Bok, Marina, Betanzos San Juan, Rafael, Malito, Juan Pablo, Marcoppido, Gisela Ariana, Franco, Diego Rafael, Militelo, Daniela Ayelen, Schammas, Juan Manuel, Bari, Sara Elizabeth, Stone, William B., López, Krisangel, Porier, Danielle LaBrie, Muller, John Anthony, Auguste, Albert J., Yuan, Lijuan, Wigdorovitz, Andres, Parreño, Gladys Viviana, Ibañez, Lorena Itat
Formato:	info:ar-repo/semantics/artículo
Lenguaje:	Inglés
Publicado:	MDPI 2024
Materias:	Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Antibody Reactions Transgenic Animals Mice Nanobiotechnology Coronavirus del Síndrome Respiratorio Agudo Grave 2 Reacción Antígeno Anticuerpo Animales Transgénicos Ratón Nanobiotecnología SARS-CoV-2 Intranasal Treatment Tratamiento Intranasal
Acceso en línea:	http://hdl.handle.net/20.500.12123/18374 https://www.mdpi.com/1999-4915/16/2/185 https://doi.org/10.3390/v16020185